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Letter from the Editor
Dear Readers,
We thank you for supporting us as this
is our 8th issue of Osmosis! Even in
times as rough as these, I’ve been
proud to work with a team of editors,
writers, and designers who have been
willing to continue talking about science. I hope you enjoy this issue and
take it as an opportunity to read about
some fun science. I wish the future
teams on Osmosis the best of luck and
I know you’ll do us proud!
As always, Science on!
Anthony Isenhour

A Big Thanks from our Executive Team!
Editor-in-chief: Anthony Isenhour
Associate Editor: Joseph McEachon
Managerial Editor: Cassidy Hilton

PR and Social Media: George Qiao

Good luck to upcoming executive team!
Ryan Shah, Lily Dickson, Ryan Cvelbar, and Caterina Erdas
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By Rilyn McKallip
Biological weapons, as defined by the Federation of American Scientists, are “toxins and microorganisms, such as viruses and bacteria, used to deliberately inflict disease among people, animals and agri1
culture.” Biological weapons have
been used for hundreds of years on
varying scales, from the catapulting
of plague-infected corpses into enemy cities in the 14th century, to the
testing of infectious diseases in China during WWII, to the 2001 anthrax attacks. These weapons act
discreetly, as it is hard to trace an
outbreak to a particular attacker and
it takes several days for an infected
individual to show signs of the disease. Moreover, because biological weapons are often highly infectious,
their effect on society is far reaching. While state actors have made use of biological weapons in the past,
the discreet and wide-reaching aspects of biological
weapons make them increasingly appealing for terrorist groups, as they have the capability to disrupt society and cause panic.

agents that are highly contagious and have relatively
short incubation periods, high mortality rates, and the
potential to cause public panic. Some agents that fit
these characteristics, and are hence popular choices for
biological weapons, include anthrax and
2
the plague. Anthrax is the bacteria Bacillus anthracis, and it traditionally infects
people who work with animals, but it can
also be spread through aerosol. Gastrointestinal anthrax has a mortality rate of 2575%, while inhaled anthrax can have a
3
mortality rate of over 80%. Another
common pathogen used as a biological
weapon, Yersinia pestis( plague) is a bacteria that causes painful, swollen lymph
nodes, fever and extreme exhaustion. Though outbreaks traditionally began with rat-to-human transmission, plague bacteria can also be released through aerosol, and the infection easily spreads from person to
3
person. Plague mortality rate is around 50%. Both of
these diseases are commonly used as biological weapons because of their ease of spread and high mortality
rates. Scientists can obtain these biological agents
A biological weapon can be developed in three from the environment, but they are more commonly
steps—selecting a pathogen, growing and developing acquired from pathogen banks. Individuals also donate
samples of the pathogen, which scientists can genetthe microorganism, and preparing the disease for delivery. When selecting the pathogen, the designers of ically modify into a biological weapon.1
the weapon must consider how the biological agent
After choosing and acquiring the biological
spreads, how long it incubates, and how destructive it
agent, scientists use genetic engineering technology to
is. Generally, weapon developers aim to use biological
4

alter the pathogen to be more resilient and lethal. Using gene editing technology, scientists can change the
genetic material of pathogens by either inserting
genes, deleting genes, or altering existing genes to
produce pathogens with desired traits. Bacterial agents
may also be altered to be resistant to antibiotics,
which makes infections resulting from these bacteria
4
difficult to treat. This biotechnology is expensive,
however, and acquiring it is a hurdle for groups attempting to develop effective biological weapons.
Once the pathogen is edited, scientists must
choose a method of delivery. The most common methods of spreading biological weapons are through the
air using bombs or sprays, through the water supply,
and through the food supply. The Japanese commonly
used aerosol pathogens in their tests on China in
World War II, and there are documented instances of
salmonella and E. coli being deliberately added to
5
food, such as salad bars. The chosen method of transmission will depend on how widespread or controlled
the attack is intended to be.

gram, the Soviet Union stockpiled anthrax bacteria
and smallpox viruses undetected until the program’s
5
dissolution in 1992. In addition to non-compliance in
state actors, non-state actors have made use of biological weapons. The anthrax attacks of 2001 were carried
out by a non-state actor, as was the spread of salmonella through salad bars by a religious sect in the
5
1990s. The ease of access to biological agents makes
bioterrorism, the use of biological weapons by a nonstate actor to reach a political goal, a real and growing
threat.

What can be done to combat the threat of bioterrorism? Perhaps the most important step is being
prepared for an attack. The U.S. can invest in stockpiling vaccines for diseases like anthrax and the plague,
researching possible new pathogens that could be used
as biological weapons, and modeling possible outcomes of a biological attack. We can use what we
know about the development of biological weapons to
learn how to best protect ourselves from them,
through modeling various diseases in different formats
International treaties have been implemented and mutations, and using these models to form plans
to combat these pathogens. Additionally, there is the
to slow or prevent the development of biological
growing field of bioterrorism forensics, which aims to
weapons. The 1925 Geneva Protocol banned use of
use DNA evidence to identify pathogens that could be
biological weapons in warfare, and the 1972 Biologi6
cal and Toxin Weapons Convention (BTWC) went a developed into biological weapons. While it is impossible to predict the exact timing and details of an
step further to prevent development, production,
1
attack, it is possible to prepare for possible attacks.
stockpiling, and acquisition of biological weapons.
Additionally, good hygiene practices, such as washing
However, it is nearly impossible to make sure that
countries follow these treaties, and underground bio- hands and staying up to date in vaccinations, can help
logical weapon programs continued, even in signatory individuals avoid contracting illnesses released by biological weapons. The threat posed by biological
countries. For example, the Soviet Union signed the
weapons and bioterrorism is present and growing, but
BTWC but then started Biopreparat, a well-funded
biological warfare research project. Through the pro- there are measures that can be taken to protect us from
a deadly attack.
References
1 Introduction to Biological Weapons. (2013).Federation of
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bwintro.html.
2 Biological Agents/Diseases. Center for Disease Control.
Retrieved March 6, 2020, fromhttps://emergen
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Brains on Batteries: The Potential of
Deep Brain Stimulation
By Joshua Pandian

For 40 years of her life, Edi Guyton could not experience happiness. Despite having a family and a successful career, she still struggled to feel happy. She
tried various therapies and medications, but to no
avail. Then, in 2007, Edi Guyton underwent an experimental procedure that allowed her to smile genuinely
for the first time in her life. Due to two electrodes
implanted in her brain and a small battery pack near
her collar bone, Edi is now able to experience the joys
of life like everyone else.10 Deep brain stimulation
(DBS), the process of implanting electrodes into the
brain to lessen the symptoms of neurological diseases, began as an experimental idea based on early
pain-processing theories. Today, DBS is used to treat
various neurological disorders, including Parkinson’s
disease, depression, OCD, and chronic pain. While
major advancements have been made in recent
years, DBS is still in its infancy and possesses a tremendous potential to advance human well-being as
our knowledge of neuroscience increases.

process, in which pain signals are processed via the
spinal cord before reaching the brain. Then, in 1969,
D.V. Reynolds discovered a top-down process in
which the brain receives pain signals first and proceeds to inhibit them. In his study, Reynolds stimulated the periaqueductal gray regions in the midbrain of
rats and performed surgery on them without anesthesia. The rats felt no pain for the duration of the
surgery.3 This phenomenon occurs because the periaqueductal gray region has associations with nerve
fibers that send signals to the dorsal horn of the spinal cord, the same area where pain is inhibited during
gate-control.2 Reynold’s study demonstrated that the
brain also has the ability to inhibit pain.

With the knowledge that pain can be inhibited from
the spinal cord or from the midbrain, researchers
attempted to cure chronic pain using two approaches. The first approach is spinal cord stimulation,
which involves placing electrodes in the spinal cord to
generate a pulse to keep pain signals from reaching
the brain. This method of treating pain was originally
The History of Deep Brain Stimulation
believed to work due to gate-control theory, but curThe discovery of deep brain stimulation began in
rently research has shown that there may be more
1965 when Ronald Melzak and Patrick Wall proposed factors at play. Essentially, the added electrical sigtheir gate-control theory of pain. Through their stud- nals from the electrodes inhibit the pain signals from
ies, Melzak and Wall discovered that nerve fibers that reaching the brain.5 As a result of its success, spinal
transmit information about touch and vibration are
cord stimulation was FDA approved and used as a
more myelinated, and therefore faster acting than
method for pain relief.3
nerve fibers that transmit pain signals. In the dorsal
horn of the spinal cord, these fast-acting nerve fibers The second method used to cure chronic pain was
can inhibit pain signals from reaching the brain. The DBS, which was originally proposed in the 1970s.
gate-control theory explains why we tend to rub our Electrodes were placed in the thalamus, the part of
head when we hit it on a doorframe or grab our foot the brain responsible for directing pain signals for the
somatosensory cortex for processing. Unfortunately,
when we step on a Lego. Increasing touch signals
3
clinical trials did not produce convincing evidence for
helps inhibit pain.
the effectiveness of DBS.3 Today, we know this is beThe gate-control theory of pain gave rise to ideas
cause the original trials were poorly executed,4 but at
about how pain can be controlled from a bottom-up the time, it appeared DBS had reached an end.
6

DBS seemed to be a failed idea until the 1980s, when
it was found to be effective in countering motor
symptoms associated with Parkinson’s disease.3 Increased knowledge of the brain regions associated
with Parkinson’s disease allowed scientists to better
target areas to stimulate to help counter irregular
activity. Even today, our knowledge of these brain
regions continues to expand. For instance, a 2018
study on the interactions between the basal ganglia
and thalamus revealed that in low dopamine environments, inhibitory output from the basal ganglia
can cause rebound firing in the thalamus, leading to
motor symptoms associated with Parkinson’s disease.6 Modulating basal ganglia output or the rebound firing can help eliminate involuntary muscle
contractions, so DBS can potentially be the answer to
this problem.

Where is DBS Today?
After DBS was first approved in 1997, the applications of it have expanded beyond Parkinson’s disease. One example of this is the use of DBS to treat
certain types of depression. In 2005, Dr. Helen Mayberg used DBS on Brodmann area 25, a part of the
brain that has been identified as overactive in individuals with treatment resistant depression. According to the study, stimulating this region with electrodes can help decrease activity in the region, which
in turn affects the hypothalamus and the brainstem.
For patients receiving this treatment, this means
better sleep, motivation, and energy. As this study
shows, DBS is effective because it modulates multiple
functions in the brain by changing processes in the
target site and downstream.7
Patients suffering from obsessive compulsive disorder (OCD) may also be able to benefit from DBS. A
recent study showed that targeting one of five possible brain areas can relieve OCD symptoms. However,
it appears that stimulating the different regions have
different impacts on the brain, so a more personalized approach must be taken to provide the appropriate treatment to each patient.8
Advances in using personalized DBS techniques have
led researchers to again attempt combating chronic
pain with DBS. Dr. Shirvalkar, an associate professor
of anesthesiology at UC San Francisco, is using the

technology available today to monitor neural activity
over time in order to create DBS with varying electrical pulses depending on the situation.9 Studies such
as these show promise for DBS to be more accurate
and effective in the future.

What still needs to be done?
Although DBS is becoming more effective over time,
there is still plenty of room for improvement. One of
the biggest challenges facing the advancement of
DBS is the current lack of understanding about how
certain brain functions interact. While research can
often get general ideas for what different brain regions do, it is still difficult to target which area to
place the electrodes in order to have effective DBS.
This is seen from the studies of DBS on OCD, where
treatments of multiple brain regions appear to ease
symptoms, but in different ways.8 Also, in some cases, a patient’s brain can become used to the deep
brain stimulation, thus rendering the treatment ineffective. More research must be done in order to
understand why DBS may cease to work in some patients.1 As research on the topic expands, patients
will benefit from having DBS that is more personalized and effective in treating their specific condition.
References
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Coronavirus is spreading fast,
but what is spreading faster?
By Dana Morcillo

What is the coronavirus?
The term coronavirus refers not to the newest, mysterious disease that is
slowly spreading globally, but rather a family of viruses. These viruses are the
source behind common illnesses such as the common cold to the more recent
outbreaks of the coronavirus disease 2019 (COVID-19). Other more severe diseases have occurred before then such as the Severe Acute Respiratory Syndrome
(SARS) in 2003 and Middle East Respiratory Syndrome (MERS) in 2012. However, both had a combined number of only 29 cases in the United
States.4Coronaviruses are animal-borne diseases meaning they begin as diseases
in mammals or birds. Although animal-borne viruses are usually not able to
transfer to humans, a virus can mutate allowing it to be transmitted to humans.
Once transmitted to humans, the coronavirus often causes an upper respiratory
infection with mild symptoms, but certain types such as MERS and SARS will
have more severe symptoms.2

How
COVID-19was first discovered in the Huanan Seafood
Wholesale Market in Wuhan, China, in December of 2019.1,2The
Huanan Seafood Wholesale Market is a wet market where live animals are bought and sold. Through the close proximity of the animals
and humans, the virus would have been able to jump from animals to
humans. While the disease is believed to have originated from the
bats, pangolins -an armored nocturnal mammal -are believed to act as
an intermediary before passing over to humans.3Studies into past
coronaviruses have found similar transmittance with SARS being
transmitted from civet cats to humans and MERS being transmitted
from dromedary camels to humans.1

did it originate?

References
1. Abutaleb, Y. (2020, January 24). How the new coronavirus differs
from SARS, measles and Ebola. Retrieved from https://
www.washingtonpost.com/health/how-the-new-coronavirusdiffers-from-sars-measles-and-ebola/2020/01/23/aac6bb063e1b-11ea-b90d-5652806c3b3a_story.html
2. Centers for Disease Control and Prevention. (2019). About Corona
virus Disease 2019 (COVID-19). Retrieved fromhttps://
www.cdc.gov/coronavirus/about/index.html
3. France-Presse, A. (2020, February 7). Pangolins may have spread
coronavirus to humans. Retrieved from https://
www.theguardian.com/world/2020/feb/07/pangolins-mighthave-spread-coronavirus-to-humans

4. World Health Organization. (2019). Coronavirus. Retrieved
fromhttps://www.who.int/health-topics/coronavirus
5. Zeng, Jing. (2020, February 27). Sensationalist media is exacerbating
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How does it spread and what
are the symptoms?
Due to the novelty of COVID-19, how it spreads is mostly based on previous
coronaviruses such as the common cold, SARS and MERS. There are two believed
paths in which transmission for COVID-19 occurs: person-to-person and contact with
infected surfaces and objects. Person-to-person transmission is the most likely route
according to the CDC.2This can happen through close contact within 6 feet or coughing
and sneezing which produces infective respiratory droplets. Contact through infected
surfaces and objects is a less likely route. It occurs through an individual touching an
area with the virus present and then touching their mouth, nose, or eyes.2
If infected, symptoms may appear between 2 to 14 days after exposure. A mild
infection includes symptoms of fever, cough, and shortness of breath or difficulty
breathing. A severe infection leads to severe illnesses suchas pneumonia.1,2Moreover,
it’s believed that infected individuals are most contagious when they exhibit the most
symptoms or are most sick. However, it’s possible for individuals to still spread the
coronavirus without showing symptoms, but this isn’t believed to be the main way the
disease is spreading.2

[

So, what is spreading faster than coronavirus?

]

Stigmas. COVID-19 is the official name used by the CDC, but often -and even now -the virus was referred to
as the “Wuhan virus” or the “China Virus.” While COVID-19 did originate in Wuhan, China, the words and language used when
speaking about the virus are important. They carry power. More importantly, they carry the power to hurt. Globally, there has
been an increase in xenophobic and overall, racist attacks. In Australia, parents refused to let their children be treated by Asian
doctors.5 In Canada, a petition was formed and signed by over 10,000 residents to track and name Chinese-American students
after any travel to China.6 In America, Chinese restaurants are struggling to stay afloat after business has gone down and racist
attacks have been seen on public transits from the West to East Coast.7 A survey by the Asian Pacific Policy & Planning Council (A3PCON) has received over 1,100 reports of racist attacks from being coughed or spat at to physical assault.8 However,
these racist attacks don’t only affect Asians and Asian Americans but other minorities as well.
While the CDC has officially recommended that all Americans wear face masks, minorities are afraid of the larger implications at hand.9 Historically, bandanas when worn by Hispanics or African Americans have been strongly associated with
gang involvement and violence. The worry then becomes that minorities wearing masks made of bandanas or other materials
will be stereotyped and targeted. The most recent instance being two African American men who claim to have been escorted
out of Walmart for wearing masks.10
Going forward, it’s important that all individuals feel safe and accepted during such a fearful time. COVID-19 does not
discriminate. All individuals are susceptible to it, especially our medical and essential workers. While we can do our duty of
social distancing and staying at home to protect others, we also have a greater duty. To speak accurately and empathetically
when it comes to COVID-19 and those affected by it. By knowing and understanding the facts can every individual prevent the
spread of stigmas and hate, but instead foster compassion and understanding.

7. Escobar, Natalie. (2020, March 4). When Xenophobia Spreads Like A Virus.
Retrieved from https://www.npr.org/2020/03/02/811363404/whenxenophobia-spreads-like-a-virus
8. Jeung, Russell. (2020, March 25). Incidents of Coronavirus Discrimination.
Retrieved from http://ww.asianpacificpolicyandplanningcouncil.org/
wp-content/uploads/A3PCON_Public_Weekly_Report_3.pdf
9. Centers for Disease Control and Prevention (2020) Recommendations Regard
ing the Use of Cloth Face Coverings, Especially in Areas of Signifi

cant Community-Based Transmission. Retrieved from https://
www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/cloth-facecover.html
10. Melendez, Lyanne. (2020, April 9). Coronavirus help: Berkeley-based pro
gram to distribute medical masks to African American, Latino com
munities https://abc7news.com/coronavirus-bay-area-lockdownshelter-in-place-update-california-covid-cases/6090822/
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Wolves and Ravens: Defining a unique relationship
By Caterina Erdas

I

barely felt the cold, dry Montana air pierce my
lungs as I looked through my scope for an iconic animal in our culture: a wolf. While the dramatic
thermal features on the south side of Yellowstone
National Park attract the most visitors, the north is
quiet and rich with life. The Lamar Valley is a stunning stage for Yellowstone’s wildlife to interact
with one another. As the sun rises and hits the
mountain tops, the cold air rushes into the valley and
creates a thick fog, a curtain. Backstage, the wooded
mountain ranges slowly bleed into the tall grasses
and sage bushes blanketing the valley ground. Finally, I saw a black wolf’s head peeking above the tall
grass. Another five followed, probably from the
Junction Butte Pack who currently hold control over
the Lamar Valley.

after re-introduction and by extension, the rest of the
ecosystem stabilized. One hundred years later, seven
generations of wolves have lived in Yellowstone
and the surrounding area. That’s seven generations
of wolf packs fighting to expand their territory, winning, defending, losing, and dissolving as new packs
grow (yes, it’s Game of Thrones with wolves).
YNP’s wolf sanctuary provides a unique opportunity
to study wolf behavior and biology, wolf pack dynasties, and their effects on the local ecosystem.

Apart from their own pack, wolves interact
with ravens more than any other animal. The ravens
are the most obvious beneficiary from the wolfraven relationship. Studies have found that 100% of
wolf kills are visited by ravens and nearly 2/3 of the
carcass is consumed by the raven. The official term
for their relationship is predator-scavenger interspeBy the 1920s, wolf populations were comcific kleptoparasitism, or, in English, a relationship
pletely culled at Yellowstone National Park (YNP) between two different species where the scavenger
by park officials and licensed hunters trying to pro- benefits off the predator by stealing a portion of
tect their prime attractions: elk and other big-game their food. The ravens stay close, recognize a wolf’s
animals. Wolves are the number one natural preda- hunting cry, and follow the hunt from above. Ravens
tor of elks, and at the time, there was concern that
cannot open a carcass on their own, so without the
wolves were a danger to big-game animals. Howev- wolves’ help, the eyes are the only edible part of the
er, after the wolves were removed, park officials and carcass for a raven. In this instance, the wolf is the
scientists started to notice over-grazing on young
predator being taken advantage of by the raven.
trees, rampant erosion, and unstable growth/crash
However, wolf and raven behavior doesn’t
cycles in elk populations. Therefore, in 1995,
perfectly fit the kleptoparasitism model. After a kill,
wolves from Canada were brought into YNP to bal- wolves will only eat their preferred cuts of the meat
ance the ecosystem. To what extent wolf reand ignore the ravens and other scavengers pecking
introduction “saved” the greater Yellowstone ecoat the opened carcass by their side. If this were truly
system remains debated, but elk levels stabilized
a competitive or parasitic relationship, the wolves
10

would protect their meal like they often do against
bears. Even more counter intuitive, ravens are scared
or “shy” of large carcasses and won’t feed on them
unless a wolf is nearby. In addition. though wolves
were gone from YNP for 70 years, ravens preferentially follow wolves significantly over coyotes or
elk. If ravens were solely opportunistic, then a raven
would choose a carcass without a wolf and would be
equally likely to follow coyotes. These odd behaviors hint at an innate, ancient, and evolved mutualistic, not parasitic, relationship between wolves and
ravens.
Wolves obviously don’t mind ravens and
have evolved with ravens, so what are they wolves
getting out of their relationship? When wolves and
ravens are preoccupied with feeding, the ravens remain extremely alert and will call out if danger is
near. The ravens act as another set of eyes and ears,
not only at a carcass, but in the sky. Ravens have on
multiple occasions been observed locating, harassing, and yelling at injured elk to draw the attention
of wolves.
Furthermore, there are numerous wolf-raven
anecdotes that illustrate their special relationship.
For example, a biologist studying wolves wrote
about an interaction he saw of a raven pecking at the
tail of a wolf and jumping away when the annoyed
wolf snapped back in retaliation. A wildlife photographer saw a nearby wolf open up a bear carcass for
a yelling raven who found the body. One wolf
watcher noticed that ravens hang around wolf dens
and play with three-week-old wolf cubs. Both ravens
and wolves have the social abilities to form bonds
between individual ravens and individual wolves. I
have my own anecdote. Soon after spotting the
wolves, I saw a raven. At first it was circling close
above, but then it swooped down towards a wolf,
taunting it. The wolf, in turn, jumped up and snapped
its teeth at a safe distance from the raven. They repeated this dance a couple times. What at first
looked like an aggressive interaction was actually
two friends, playing. Watching the wolf and raven’s
unique relationship play out in the Lamar Valley is a
moment I will never forget.
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What’s the Hang-Up on Hangovers?
By Anthony Isenhour

G

etting a hangover after drinking the night be-

and antidiuretics (which control how much water your

fore can lead to varying regrets the next

body holds).3 Similarly, drinks like red wine, rum, and

morning depending on a variety of factors

whiskey have more of the other chemicals that may

including gender, weight, food consumption, and alcohol make hangovers more severe such as methanol.4
consumption. What a hangover feels like can vary a lot
too: headaches, nausea, fatigue, etc.

However, in delving into the personal and genetic factors that contribute to hangovers, studies have

Scientists are interested in understanding hango- found that the sons of alcoholic parents (who are at
vers and how to prevent them because they experience

greater risk for alcoholism) have more frequent hango-

them too. In order to better understand hangovers from

vers.5 This could stem from genetic factors, as well as

a scientific perspective, a unifying definition needed to

environmental factors affecting diet and approach to

be set. In 2016, some scientists worked with consumer

alcohol consumption. Similarly, scientists have seen that

descriptions and experts to define a hangover from alco- guilt about drinking and higher levels of anger or depreshol as referring “to the combination of mental and physi- sion are associated with experiencing more hangovers.6
cal symptoms, experienced the day after a single episode Stress has been shown to bring on similar symptoms to
of heavy drinking, starting when blood alcohol concen-

hangovers and the scientists who saw the above emo-

tration approaches zero.”1 Nonethelss, scientists are still

tional ties to hangovers believe that this combination of

confused about how hangovers work, and why only

different types of stress may be what is causing more

about 75% of people report having ever experienced a

hangovers. So if you’re getting ready for a night out to

hangover.2

relieve some stress, be wary of how you might feel the

`

There are a variety of potential factors that

affect hangovers, stemming from how the body breaks

next morning.
Not only do all of these factors contribute to

down the alcohol, to other chemicals in the drinks, as

hangovers, but it is found that gender does as well. Re-

well as genetics and personal factors. Studies have

search shows that women reach a higher blood alcohol

shown that some metabolic pathways other than just

content (BAC) with the same amount of alcohol, but that

breaking down the alcohol (ethanol) seem to be involved men typically consume more alcohol in a single drinking
in hangovers and involve molecules like vitamin B6, zinc,

session leading to typically higher negative consequenc-

12

es. When studies take all of these factors into account, it

seems that men are less sensitive to the adverse effects
of alcohol (aka hangover symptoms) at the same BAC.7
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Tree Man Syndrome
By George Qiao

Imagine a condition in which lesions that grow on your appendages are so severe that you cannot
use your hands and feet properly. Moreover, these lesions are large and painful, and prevent you from being
able to perform daily activities. Surgery, a common answer for this condition, can temporarily control the
growths, but the lesions continue to grow back after each surgical operation. Currently, there is no cure, and
the treatments only offer a temporary fix. Therefore, you are faced with a lifelong condition that severely
limits your ability to live a normal life. Though there are many debilitating diseases, few of them are not
given much attention. For example, one extremely rare disease is Epidermodysplasia verruciformis (EV), or
tree man syndrome, characterized by bark-like warts growing on the body.1 Although the exact number of
cases of EV is uncertain, about 200 cases in the world have been reported thus far.2

Discovered in 1922, EV is an autosomal recessive disorder that increases one’s susceptibility to the
human papilloma virus (HPV) and is characterized by lesions that resemble wood. Furthermore, EV increases one’s risk of developing skin cancer.3 HPVs are non-enveloped, double-stranded DNA viruses responsible for many lesions and cancers, and are often sexually transmitted.4 They infect the stratified epithelium of the epidermis, and do not lead to symptoms for most individuals, although some cases can involve development of warts. For infected individuals who show symptoms but are not suffering from EV,
the warts are not as vast in number as those in patients with the mutations associated with EV.5

Researchers have generally attributed EV to mutations in the EVER1 and EVER2 genes, also
called TMC6 and TMC8, respectively. These genes code for transmembrane proteins of keratinocytes,
which are epidermal cells targeted by HPV. The proteins bind to and form a complex with a zinc transporter
protein called zinc transporter 1 (ZnT-1). The EVER-ZnT complex transports zinc from the cytoplasm into
the endoplasmic reticulum of the cell, directly decreasing the amount of zinc in the cytoplasm and indirectly
decreasing the amount of zinc in the nucleus.5,6 Zinc is an ion vital for the function of AP-1 transcription
factors which promote expression of the HPV genome. The EVER-ZnT complex limits the activity of AP-1
transcription factors by decreasing the concentration of zinc in the nucleus, thereby limiting the ability of
HPV to replicate.7 A mutation in either of the genes EVER1 or EVER2 would prevent the proper functioning of the EVER-ZnT complex and allow the proliferation of HPV. With the mutation, HPV infection can
lead to uncontrolled division of keratinocytes, resulting in bark-like warts, especially on the hands and feet.1
Immunohistochemistry with antibodies specific for HPV can detect HPV infection in keratinocytes and is
used to diagnose patients with EV.2

Several treatments exist to combat EV, although there still remains no cure. The condition can be
treated with surgery, which can remove the growths. However, surgery only offers a temporary solution to
the condition, as the warts often return after surgery. One man in Bangladesh suffering from EV underwent
multiple surgical operations to remove his warts in 2016. Although the surgeries granted him the ability to
use his hands and feet for a period of time, the warts returned. Since 2016, he has had 25 surgeries, and has
not found a permanent solution to the condition.8,9 Other treatments include cryotherapy, interferons, and
14

retinoids, all of which also offer temporary solutions to the problem.9, 10

Further research on EV should be conducted so that the scientific community can come closer to a
cure for this debilitating disease. One path to take is to determine different possible causes of EV. Despite the
experiments performed to determine the role of the EVER genes, it is not certain that a mutation in these
genes is the sole cause of EV. In a particular study involving 41 EV patients, mutations in the EVER genes
were present in 75 percent of the patients but absent in the remaining 25 percent, suggesting that there are
other possible causes of EV.6 Thus, more research should be conducted to identify alternative causes of the
condition. If we can determine the different mechanisms of action of this disease, we can come closer to a
cure by directly targeting those mechanisms. Hopefully, in the future, we can find a solution that can help
end the suffering of those affected by the disease.
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Our Future in a 3-D Printer
By Ryan Cvelbar

CareCloud, a privately held technology company headquartered out of Miami, states that according to recent figures, the average cost of an organ
transplant in the U.S. can reach well over $1 million. Furthermore, according to the United Network
for Organ Sharing (UNOS), more than 113,000 patients in the U.S. are currently waiting for an organ
transplant. Anne Paschke of UNOS stresses this need
for organs by expressing that only 1 to 2 percent of
the population dies in a way that
makes them potential organ donors.
Although the need for organs has yet
to be met, bioprinting has the potential of saving lives by addressing this
chronic shortage through various applications.
Many of you may have heard
of 3-D printing, but have you heard
of bioprinting? Bioprinting is a biotechnology that does not fail to excite
optimists in the biotech industry.
Specifically, bioprinting is “an additive manufacturing process where
biomaterials such as hydrogels or
other polymers are combined with cells and growth
factors, and then printed to create tissue-like structures that imitate natural tissues” (What). You may be
wondering how exactly this printing process takes
place. Futurity explains that bioprinting involves using a computer-guided pipette that takes up cell cultures and “prints” them out in gel layers onto biopaper. This biopaper degrades over time; leaving behind the printed structure. According to the Australian Academy of Science (AAS), every tissue in the
body is naturally made up of different cell types, so
the required cells are taken from a patient and cultivated until there are enough to create cell specific
‘bio-ink’ that is loaded into the printer. Moreover, the
AAS explains how these cells seek out similar cells
to join with much like the way cells in an embryo develop in the womb during embryogenesis, or tissue in
an adult moves to repair damage. Because the parts
are synthesized from the organ recipient’s genetic
matter and precisely match the tissue or organ being
replaced, CareCloud states that there is less of a
chance that the immune system will reject the foreign

tissue. Now that we have covered the basics of sourcing, growing, and implanting bio-prints, let’s talk
about bioprinting’s potential applications.
From patient-specific surgical models and
personalized medicines to replacement body parts
and custom-made prosthetics, the possibilities of bioprinting are endless. A serious car accident that results in a passenger’s nose being shattered serves as a
great example of a situation in which bioprinting can
be put to use. According to the AAS, bioprinting technology makes it possible to
reconstruct this nose as a 3D model on the
computer. A biopsy can simultaneously be
performed on the patient while cartilage
cells are extracted from the knee, finger,
ear or splinters of the shattered nose. The
cells are reproduced in the laboratory and
mixed with a biopolymer, which is then
used to print a new nose to be implanted
during surgery. In this process, the biopolymer is used as a form of shaping mold
that is gradually broken down by the body
and replaced by its own cells. This replacement leaves the implant unrecognizable as it appears cohesive with the individual’s own
skin and cartilage. Moreover, Futurity forecasts that
mass-supplied prosthetics are likely to be a thing of
the past as 3D printing is increasingly used to manufacture prosthetics that are tailored to a patient’s anatomy and needs. For example, Futurity explains that
surgeons have to cut a patient’s bone to fit the prosthetic in a hip-replacement, but in the future, it will
be normal to 3D print a prosthetic to fit a patient. Additionally, bioprinting has extensive applications in
the pharmaceutical industry with the potential to
drastically reduce the need for animal trials in drug
testing. Cellink contends that this technology offers
the potential to test treatments for diseases using artificially affected tissues, eradicating organ donation
and transplantation. Perhaps bioprinting’s most significant application is the use of 3D printed models to
practice surgical operations. According to Jason
Chuen, Director of Vascular Surgery at Austin Health
and a Clinical Fellow at the University of Melbourne,
studies have shown that operations can be completed
faster and with less trauma for patients and the poten16

tial cost savings alone are considerable. Although
these ideas sound both exciting and feasible, professionals have a long way to go until these applications
become reality.
Aside from potential applications of bioprinting in the medical field, professionals are currently
making progress in the development of bioprinting as
it pertains to some similar applications. “In 2003,
Wake Forest succeeded in printing the first fully functional mini-kidney, which was able to filter blood and
produce urine. Since then, scientists have been working to develop more sophisticated organs like hearts,
livers and uteruses” (Carecloud). Chuen explains that
once inside the gel, cells can die in a matter of
minutes. This isn’t a problem for small structures like
organoids, an artificially grown organ, that can be
built quickly and then transferred back into a nutrient
solution, but it is a problem when attempting to print
an organ because the initial layers of cells will die before the organ is completed. Dave Fornell of Diagnostic and Interventional Cardiology argues that the
Achilles heel of tissue engineering today is the need
to create vascularity in the structure. He states that the
key to printing vascularizable micro-organs involves
chemical modifications of alginate hydrogels to promote organoid vascularity and suppress inflammatory
responses. According to Fornell, what we can print
right now are cardiac patches and small- to mediumsized blood vessels, skin tissue, soft tissue for reconstructive surgery, and vascularized micro-organs that
can be grown in a bioreactor and used to supplement
the function of a diseased organ like the liver.

ation, you can have a heart made out of your own cell
tissue. The biotechnology industry is growing at an
unprecedented rate and the prospects of bioprinting
applications like these give us a lot to look forward to.
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to create ‘living’ blood vessels by enabling small
blood vessels to develop on their own. “Over a period
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nutrients to the cells on their own—mimicking the
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It is no secret that modern medicine has improved people’s lives in virtually every are of healthcare.
What is also not a secret is how expensive it is. . Not only does the average American spend roughly $5000 on
healthcare, they also spend roughly $1200 on pharmaceuticals. The candidates gunning for the U.S. presidency often bring up the topic of rising pharmaceuticals and what they would do to change it. Medical services
and products as a whole are of concern for virtually all Americans, and many of them are considered overpriced. The development of these products isn’t cheap, and it needs funding. On the other hand, citizens would
rather spend that $1200 on other commodities. Looking at the path of funding for pharmaceuticals and biomedical research as a whole can help people understand why.
Let’s take a quick look at biomedical research as a whole. Though biomedical research in the United
States is funded through multiple channels, the largest funder of federal research is the National Institutes of
Health (NIH). Comprising of 27 institutes and centers in the U.S., it pours over $40 billion into research,
mainly in the form of grants. These grants are awarded to research institutions, mainly universities and medical schools, where some of the science is done, and about 10% of funding goes to in-house NIH research. NIH
-funded projects cover a wide range of research areas. Some of their biggest in-house projects include cancer
research; the National Cancer Institutes budget was $5.098 billion. What’s interesting, however, is that this
number (just over $40 billion) has remained relatively stagnant over the past two decades and has failed to
keep up with inflation. As a result, less and less projects are being funded - approximately one in five and less
research is able to be done.
Pharmaceutical research, on the other hand, is often done by private firms. These firms both raise money and perform the resulting research. For example, The Pharmaceutical Research and Manufacturers of
America (PhRMA) report that $97 billion was spent in 2017 by biopharmaceutical companies on research and
development (R&D). This industry alone, then, spends more than double the NIH’s research funding on their
projects.
These two areas of healthcare are different in several ways, mainly that pharmaceuticals offer one
product - drugs - while biomedical firms and institutes offer a variety of services. However, there is another
key distinction:government institutes like the NIH are, well, publically funded, while private institutes like
Novartis and Pfizer are for-profit. As much as these firms claim they are trying to save lives, at the end of the
day they are also trying to maximize their profits and will sell their products at the price the market can bear.
Unlike the NIH, private firms gather their research funds from their profits, meaning they can only produce
beneficial drugs as long as they are making a profit. When that stops happening, they either raise prices or
look for another way to make money.
The path for funding for biomedical research and pharmaceutical development is a complicated one. It
has clear advantages: institutions across the country are diligently working to produce innovations, improvements, and efficiencies in the world of medicine. Funding a large number of research programs also results in
a large number of different and varying ideas. The path isn’t perfect, though. A shrinking NIH budget and increasing pharmaceutical company profits paired with increasing pharmaceutical drug costs are concerning
many Americans who struggle to pay for healthcare.
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